Pathogenesis of systemic sclerosis;Étiopathogénie des sclérodermies

Revue du Praticien

Volumn 52, Issue 17, 2002, Pages 1873-1881

  Marie, Isabelle ^a  

^a Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENVIRONMENTAL FACTOR; FIBROSIS; GASTROINTESTINAL DISEASE; GENETIC PREDISPOSITION; HEREDITY; HUMAN; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; LUNG FIBROSIS; OCCUPATIONAL EXPOSURE; REVIEW; SCLERODERMA; SYSTEMIC SCLEROSIS; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VIRUS INFECTION; CARDIOVASCULAR SYSTEM; ENVIRONMENT; GENETICS; PATHOLOGY; PATHOPHYSIOLOGY; SKIN;

CARDIOVASCULAR SYSTEM; ENVIRONMENT; FIBROSIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; SCLERODERMA, SYSTEMIC; SKIN;

EID: 0036846322     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Marie I, Levesque H, Courtois H. La D-pénicillamine: Un traitement dépassé de la sclérodermie systémique? Rev Méd Interne 1999; 20: 1077-81.
2. Marie I, Levesque H, Dominique S et al. Atteinte pulmonaire au cours de la sclérodermie systémique. Partie I: Pneumopathie interstitielle chronique fibrosante. Rev Méd Interne 1999; 20: 1004-16.
3. Marie I, Levesque H, Ducrotté P, Courtois H. Atteinte de l'intestin grêle au cours de la sclérodermie systémique.Rev Méd Interne 1999; 20: 504-13.
4. Marie I, Levesque H, Hatron PY, Dominique S, Courtois H.Atteinte pulmonaire au cours de la sclérodermie systémique. Partie II: Hypertension artérielle pulmonaire isolée, cancer bronchopulmonaire, hémorragie alvéolaire. Rev Méd Interne 1999;20: 1017-27.
5. Furst DE, Clements PJ. Pathogenesis, fusion (summary). In: Clements PJ, Furst DE (eds). Systemic Sclerosis. Baltimore:Williams and Wilkins, 1996: 275-84.
6. Silman AJ, Black CM, Welsh KI. Epidemiology,demographics, genetics. In:Clements PJ, Furst DE (eds). Systemic Sclerosis. Baltimore: Williams and Wilkins, 1996: 23-49.
7. Tan FK, Arnett FC. Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon. Curr Opin Rheumatol 2000; 12: 511-9.
8. Silman AJ, Howard Y, Hicklin AJ, Black C.Geographical clustering of scleroderma in south and west London. Br J Rheumatol 1990;29: 93-6.
9. Perez MI, Kohn SR. Systemic sclerosis. J Am Acad Dermatol 1993; 28: 525-47.
10. Silver RM. Scleroderma and pseudoscleroderma: Environmental exposure. In: Clements PJ, Furst DE (eds). Systemic Sclerosis. Baltimore:Williams and Wilkins, 1996: 81-98.
11. Artlett C, Vancheeswaran R, Black C, Welsh K. Variable number tandem repeat and fingerprint analysis of scleroderma family DNA. Am Coll Rheumatol 1993; S182: B244.
12. Emerit I, Levy A, Housset E. Sclérodermie généralisée et cassures chromosomiques. Mise en évidence d'un «facteur cassant » dans le sérum des malades.Ann Genet 1973; 16: 135-8.
13. Gay S, Boulware DW, Gay RE. Oncogenes, growth factors, and matrix in the pathogenesis of systemic sclerosis. Clin Dermatol 1994; 12: 419-24.
14. Nelson JL, Furst DE, Maloney S et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998; 351: 559-62.
15. Artlett CM, Cox LA, Jimenez SA. Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens. Arthritis Rheum 2000; 43: 1062-7.
16. Nietert PJ, Silver RM. Systemic sclerosis: Environmental and occupational risk factors. Curr Opin Rheumatol 2000; 12: 520-6.
17. Valesini G, Litta A, Bonavita MS et al. Geographical clustering of scleroderma in a rural area in the province of Rome. Clin Exp Rheumatol 1993; 11: 41-7.
18. Carpentier P, Feuillade ML, Santacreu JM, Arnaud J, Imbert B, Franco A. Variations géographiques de la prévalence et de l'incidence de la sclérodermie systémique. Rev Méd Interne 1999; 20: 560S.
19. Haustein UF, Ziegler V. Environmentally induced systemic sclerosis-like disorders. Int J Dermatol 1985; 24: 147-51.
20. Hallé O, Schaeverbeke T, Bannwarth B, Dehais J. Les facteurs d'environnement et les éléments iatrogènes dans la sclérodermie systémique et les syndromes apparentés. Revue de la littérature. Rev Méd Interne 1997; 18: 219-29.
21. Dang H, Dauphinee MJ, Talal N et al. Serum antibody to retroviral gag proteins in systemic sclerosis. Arthritis Rheum 1991; 34: 1336-7.
22. Varga J, Jimenez SA. Pathogenesis of scleroderma: Cellular aspects. In: Clements PJ, Furst DE (eds). Systemic Sclerosis. Baltimore: Williams and Wilkins, 1996: 123-51.
23. Furst DE. The endothelium in the pathogenesis of systemic sclerosis: Is it primary or secondary? J Mal Vasc 1999; 24: 95-8.
24. Matucci-Cerinic M, Kahaleh MB, LeRoy EC. Vascular involvement in systemic sclerosis. In: Clements PJ, Furst DE (eds). Systemic Sclerosis. Baltimore: Williams and Wilkins, 1996: 153-74.
25. White B. Pathogenesis: Immune aspects. In: Clements PJ, Furst DE (eds). Systemic sclerosis. Baltimore: Williams and Wilkins, 1996: 229-50.